[7] Ingrid HCV, Roland G, Hermann JG, et al. NF-κB decoy oligodeoxynucleotides reduce monocyte infiltration in renal allografts [J].FASEB J, 2000, 14(7): 815-22 [1] Harvery PR, Iu S, McKeown CM, et al. Adenine nucleotide tissue concentrations and liver allograft viability after cold preservation and warm ischemia[J]. Transplantation, 1988,45(6): 1016-20. [2] Gibbons GH, Dzau VJ. Molecular therapies for vascular disease[J].Science, 1996, 272(5262): 689-93. [3] Barnes PJ, Karin M. Nuclear factor-κB -a pivotal transcription factor in chronic inflammatory disease [J]. New Eng J Med, 1997, 336:1066-71. [4] Collins T. Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion[J]. Lab Invest, 1993, 68(4): 499-508. [5] Cines DB, Pollak ES, Buck CA, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders [J]. Blood, 1998,91(363): 3527-61. [6] Tomita N, Morishita R, Higaki J, et al. A novel strategy for gene therapy and gene regulation analysis using transcription factor decoy oligonucleotides[J]. Exp Nephrol, 1997, 5(4): 429-34. . [8] Azuma H, Tomita N, Kaneda H, et al. Transfection ofNF κ B-decoy oligodeoxynucleotides using efficient ultrasound-mediated gene transfer into donor kidneys prolonged survival of rat renal allografts [J]. Gene Ther, 2003, 10(4): 415-25. [9] Tomita N, Morishita R, Tomita S, et al. Transcription factor decoy for NF kappa B inhibits TNF-alpha-induced cytokine and adhesion molecule expression in vivo[J]. Gene Ther, 2000, 7(13): 1326-32. [10] 郑刚,张积仁,刘发全,等.脂质体介导al,4-GalT反义寡核苷酸对人脑胶质瘤细胞系SWO-38的作用[J].第一军医大学学报,2002,22(4): 299-302.Zheng G, Zhang JR, Liu FQ, et al. Effects of lipofectin-mediated a1 ,4Gal T antisense oligonucleotide on human glioma cell line SWO-38 [J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao,2002,22(4): 299-302. [11] 陈永鹏,章廉,胡俊,等.脂质体的乳糖化修饰及其肝脏靶向性研究[J].第一军医大学学报,2001,21(3):177-9.Chen YP, Zhang L, Hu J, et al. Study of lactosaminated liposome and its hepatotropic targeting in rats[J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao, 2001, 21(3): 177-9. [12] 胡俊,章廉,冯筱榕,等.一种新型脂质体的制作方法[J].第一军医大学学报,2001,21(2):138-9Hu J, Zhang L, Feng XR, et al. A method for producing a new type ofliposome [J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao, 2001, 21(2): 138-9. [13] Immai E. Gene therapy approach in renal disease in the 21 st century [J]. Nephrol Dial Transplant, 2001,16(Suppl 5): 26-34. [14] Liu F, Qi H, Huang L, et al. Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration [J]. Gene Ther, 1997, 4(5): 517-23. [15] Imai E, Isaka Y. Gene therapy for kidney disease[J]. Expert Opin Invest Drugs, 2000, 9(10): 1029-39. [16] Morishita R, Sugimoto T, Aoki M, et al. In vivo transfection of cis element "decoy" against nuclear factor-kappa B binding site prevent myocardial infarction [J]. Nat Med, 1997, 3(8): 894-9. [17] Zabner J, Fasbender AJ, Moninger T, et al. Cellular and molecular barriers to gene transfer by a cationic lipid[J]. J Biol Chem, 1995,270(54): 18997-9007. [18] Noguchi A, Furuno T, Kawaura C, et al. Membrane fusion plays an important role in gene transfection mediated by cationic liposomes [J]. FEBS Lett, 1999, 433(2): 169-73. [19] 胡英,金一,王华,等.阳离子膜融合脂质体介导反义寡核苷酸在Hela细胞中的转染试验研究[J].药学学报,2002,37(11):892-6.Hu Y, Jin Y, Wang H, et al. Study on the transfection efficiency of antisense oligodeoxynucleotide against telomerase by cationic fusogenic liposome[J]. Acta Pharm Sin, 2002, 37(11): 892-6. [20] Nakanishi M, Mizuguchia H, Ashihara K, et al. Gene transfer vectors based on Sendai virus[J]. J Control Rel, 1998, 54(1): 61-8. |